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Objectives: Mathematical models can be helpful to understand the complex
dynamics of human immunodeficiency virus infection within a host. Most of work
has studied the interactions of host responses and virus in the presence of active
cytotoxic immune cells, which decay to zero when there is no virus. However,
recent research highlights that cytotoxic immune cells can be inactive but never
be depleted.
Methods: We propose a mathematical model to investigate the human immunode-
ficiency virus dynamics in the presence of both active and inactive cytotoxic immune
cells within a host. We explore the impact of the immune responses on the dynamics
of human immunodeficiency virus infection under different disease stages.
Results: Standard mathematical and numerical analyses are presented for this new
model. Specifically, the basic reproduction number is computed and local and
global stability analyses are discussed.
Conclusion: Our results can give helpful insights when designing more effective
drug schedules in the presence of active and inactive immune responses.1. Introduction
Human Immunodeficiency Virus (HIV) is the path-
ogen which is responsible for the Acquired Immuno-
deficiency Syndrome, AIDS. Once HIV enters into the
body is detected by macrophages and a range of antigen
presenting cells; in particular, dendritic cells andted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Preventionmacrophages search, phagocytize and analyze the anti-
gen to be presented to inactivate CD4 T-cells in a pro-
cess called immune synapse or simply antigen
presentation [1]. Dendritic cells have certain lectins in
their membranes to which viral particles bind with large
affinity, this traps HIV and during the antigen presen-
tation process CD4 T-cells are more likely to getreative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
4 H.D. Toro Zapata, et alinfected by the surrounding viral particles attached to
the dendritic cell membrane [1,2].
HIV mostly targets the immune response system,
particularly, CD4 T-cells, where the viral RNA is con-
verted into viral DNA so that when these cells are
activated, they can replicate virus. CD4 T-cells are
responsible for signaling other immune responses such
as the cytotoxic and humoral responses that are invaders
that have to be fought. In particular, Cytotoxic T
Lymphocytes and CD8 cells direct cytotoxic immune
response. This cytotoxic response act by lysing infected
cells causing them to explode, thus cytotoxic cells
remove infected CD4 T-cells from the body at a con-
stant rate, but these cells do not directly target free virus.
Over the time, HIV is able to deplete the population of
CD4 T-cells in such way that the Cytotoxic response is
never depleted.
There have been remarkable attentions on the HIV
dynamics among scientists in medicine and mathemat-
ical biology. Significant efforts have been made in order
to understand and to characterize the underlying mech-
anism of the disease. Earlier mathematical framework
has been considered to model HIV/AIDS dynamics
focusing on the viral and CD4 T-cells dynamics [3e11]
and the references therein. Recently, there has been
some work to explore the impact of the immune
response in the HIV dynamics [12e15]. Specifically,
mathematical models incorporated explicitly the effect
of the immune response and their results have been
analyzed and investigated [12,14,15]. Most of work has
studied the interactions of host responses and virus in
the presence of active cytotoxic immune cells, which
decay to zero when there is no virus. However, recent
research highlights that cytotoxic immune cells can be
inactive but never be depleted.
In this manuscript, we propose a mathematical
model, which further captures active and inactive im-
mune cells in the previous models. Our main focus is to
identify the role of both active and inactive immune
responses in the HIV dynamics within a host. We
analyze a modification of the existing model [12] that
splits the cytotoxic immune cells compartment, M, into
two compartments, inactive and active immune response
cells. On one hand, this process of activation leads us to
take into account that cytotoxic cells are always present
in the body. On the other hand, inactive cytotoxic im-
mune cells get activated through specific biochemical
processes related to the presence of HIV.2. Materials and methods
2.1. Previous models
Let V(t) denote the average viral particle concentra-
tion at time t assuming that when the initial time tZ 0,
an initial viral load V0 > 0 enters into the body. In ideal
conditions, this initial viral load is going to beeliminated from the body at a constant rate c and this
depends only on the virus ability to infect the immune
cells. Therefore, as long as the infection has not been
established, the viral load can be described by
_VZ cV ð1Þ
where _V represents the rate of change in the viral con-
centration per unit time. Ata very early stage of infec-
tion, the virus doesn’t find the proper conditions for
successful replication, it decays exponentially as given
in the expression, V(t) Z V0e
ct. Perelson and Nelson
studied a similar situation to the one we just described
but there is an unknown quantity (and to be determined)
describing the creation of new viral particles [16]. To
define this quantity, first, we consider that once the virus
enters into the body and it will infect the CD4 T-cells,
which are immunologically activated T-cells. Let
T Z T(t) be the average concentration of healthy CD4
T-cells at time t at the constant recruitment rate s and
death rate m. In this way _TZs mT describes the
evolution of T without infection. In the absence of virus,
the CD4 T-cells reaches the equilibrium level of s/m
cells per mm3. If we denote b as the probability of a
CD4 T-cell for to be infected by the HIV, then from the
mass action principle, bTV represents the average
number of CD4 T-cells per unit of time that getting
infected at time t. Thus the equation becomes
_TZs bTV mT : ð2Þ
Now, the average concentration of infected CD4
T-cells is represented by the variable TZT)ðtÞ, these
are activated by the HIV aiming to replicate more viral
particles. One remarkable aspect of this disease is that
the destruction of infected CD4 T-cells was initially
thought as a consequence of cytopathic action but later
it was found other indirect destruction mechanisms
such as induction of apoptosis through soluble viral
proteins, secondary cellular death due to immunolog-
ical hyper-activation, syncytia formation and progres-
sive damage of the primary and secondary lymphoid
organs [1,17]. Let d be the infected CD4 T-cells death
rate, so dT) is the average concentration of infected
CD4 T-cells that die at a time t. Hence, the equation
describing the variation of infected CD4 T cells take
the form,
_T
)
ZbTV  dT) ð3Þ
Furthermore, let us consider that each CD4-T infec-
ted cell produces h new viral particles, then the equation
(1) becomes,
_VZhdT) cV : ð4Þ
Where hdT) represents the average number of new viral
particles produced at the time t. So far, from these
equations (2e4), we have constructed the following
system of ordinary differential equations (ODEs)
nse in HIV 5_TZs bTV  mT
_T
)
ZbTV  dT)
_VZ hdT) cV :
ð5Þ
The system (5) is the simpler model for HIV and
immune system dynamics that can be considered. It has
been widely studied by [13,18] among many other au-
thors. Different models, which are derived from this
system, have been mathematically analyzed in the
literature [2,19e21]. However, this ODE model does
not take into account the immune response (cytotoxic
immune response or humoral immune response) effect,
which is a key phenomenon in the dynamics of HIV
within a host. Nowak and Bangham have included this
effect and given as the following ODE system [12]:
_TZs bTV  mT
_T
)
ZbTV  dT) gT)M
_MZaT)M  dM
_VZhdT) cV
ð6Þ
This system includes M Z M(t), which corresponds
to the average concentration of active cytotoxic immune
response cells, i.e. cells capable of eliminating infected
CD4 T cells through cytotoxic action with a probability
g. Then, the term gT)M denotes the average concen-
tration of infected CD4 T-cells that are destroyed.
Role of active and inactive cytotoxic immune respo2.2. HIV model with both active and inactive
immune cells
We propose a new model for HIV infection in the
presence of both active and inactive immune cells,
which correspond to cytotoxic immune response of the
body by including a class of non-active immune
response cells to avoid the extinction of immune
response in the absence of HIV and so it never dies out.
The population is divided as follows: T Z T(t) and
T* Z T*(t) describe the average concentration of
healthy and infected CD4 T-cells, respectively.
M Z M(t) and M* Z M*(t) correspond to the average
concentration of inactive and active cytotoxic immune
response cells. VZ V(t) is the average concentration of
viral particles at time t. The time variation for T, T* and
V are modeled in similar manners as the ones described
in the introduction. The active cytotoxic immune
response cells, M*, kill infected cells by an average
quantity gT*M*. The detection of infection in the body
produces aT*M* active cytotoxic immune cells, there-
fore, a is a cytotoxic immune response activation rate. It
is biologically meaningful to consider g  a because it
implies that immune response cells kill more cells than
they replicate themselves by this process. The inactive
immune response is self-produced at a constant rate of l.
The infected cells stimulate the inactive immune
response cells at a rate of j. Hence jT*M indicate thenumber of inactive immune response cells that become
active. The natural death rate of both inactive and active
immune cells is denoted by r. Hence, the mathematical
model can be written as:
dT
dt
Zs bTV  mT
dT)
dt
ZbTV  dT)gT)M
dM
dt
ZljT)M  rM
dM)
dt
ZaT)M)þjT)M  rM)
dV
dt
ZhT) cV
ð7Þ
Note that last equation for system (6) differs from the
corresponding equation on system (7)in the term hT*.
Within the system (7), the factor d is excluded because
we want to consider all the cellular production of virus,
not only those who are released by the cell when it dies
out. In this model we neglect, as in [7,12,16], the loss of
virus during the infection. Once the model is formulated,
standard mathematical analysis is carried out including
the stability analysis based on the basic reproduction
number R0 (shown in Appendix).3. Results
In this section, a selection of the numerical simula-
tions from the model (7) is presented. The parameter
values that were used to obtain these simulations are
given in Table 1. Two situations have been considered
according to the changes in parameters b, namely,
R0 > 1 and R0 < 1. First, in the case of R0 > 1, Figure 1
illustrates the HIV dynamics of a patient at an initial
stage of infection with no drug treatment under four
distinct values of b. It is assumed the patient has a
normal count of CD4þ T-cells around 1000 cells per
unit volume at the beginning. As we can see in the last
panel of Figure 1, it is typical to observe the viral par-
ticles reaches the peak at around between day 20 and 40,
then, they decrease and remain low for the rest of the
simulation time duration. Also, it is clear that as greater
the value of b, greater the average of infected CD4 T
cells and viral particles. Also, the peak timing of
infected CD4 T cells and viral particles occurs earlier as
the value of b gets larger.
Once the entrance of virus is perceived, the organism
responds by activating immune response cells that fight
against the virus as shown in the two middle panels of
Figure 1. As the dynamics of the infection is explored
using four distinct values of b, each one of results show
different levels of intensity for active and inactive
Table 1. Definition of parameters and values
Param. Description Value Reference
T0 Initial value for uninfected CD4þT cells 1000 d
T 0 Initial value for infected CD4þT cells 0 d
M0 Initial value for Non-active immune cells 0 d
M0 Initial value for active immune cells 1 d
V0 Initial value for virus 0.01 d
s Source term for uninfected CD4 T cells 10 mm3d1 [22]
b Rate CD4 T cell becomes infected by virus 2.5*105 mm3d1 [22]
m Death rate of uninfected CD4 T cell 0.01 d1 [22]
h Number of virus produced by cells lysis 500 [22]
d Death rate of infected CD4 T cells 0.26 d1 [22]
c Clearance rate of virus 2,4 d1 [22]
a Rate of immune response proliferation 5*105 mm3d1 [22]
r Death rate of immune response 0.1 mm3d1 [22]
g Rate actively infected cells deleted by CTL 2*103 mm3d1 [22]
l Source term for immune response 5 mm3d1 [22]
j Rate of immune response activation 2*103 mm3d1 d
6 H.D. Toro Zapata, et alimmune responses to help reduce infected virus cells.
Next, Figure 2 displays the dynamics of infection of a
patient at an initial stage of infection when R0 < 1.
Reduction in b (below a certain thresh hold number)
leads to the reduction on the initial outbreak of infection.
Therefore, when R0 < 1, infection would not establish in
the body (the number of infected virus goes to zero
shown in the last panel of Figure 2). More extensive and
rigorous mathematical analysis and numerical simula-
tions will be needed for clarifying the impact of active
and inactive immune responses on the HIV dynamics.4. Discussion
A primary focus of this paper has been on mathe-
matical modeling of the HIV infection dynamics within
a host in the presence of both active and inactive im-
mune responses. The present study reviewed the previ-
ous mathematical models from the simple to the model
with immune responses. We propose a new model,Figure 1. Parameter b was varied to illustrate its effect on the in
(line-dot); b Z 0.000035 (dashed) and b Z 0.000045 (solid) whewhich is a natural extension of the existing model by
taking account the immune response that should remain
always in the body.
More rigorous mathematical analysis should be and
will be done in our future research. An initial stage of
the HIV dynamics is taken as a numerical example.
When one is at an advanced stage of the disease, the
HIV dynamics would be different from what we have
shown in this study. Therefore, various scenarios will be
further need to be investigated.
This work can suggest that more successful strategies
to control HIV infection when the immune system is
more efficient in eliminating infected cells. If the im-
mune system is efficient (strong immune response), then
it is possible to maintain the effectiveness of treatment
for a longer time and at lower. Such strategies should
contribute to build effective immune memory against
the virus, and hence reduction of treatment costs and the
side effects associated with the patient on multiple HIV
therapies. The further study, which involves optimal
drug interventions, will be carried out in our futurefection’s evolution at b Z 0.000015 (dotted), b Z 0.000025
n R0 > 1.
Figure 2. Parameter b Z 0.000004 is used to illustrate no infection occurs when R0 < 1.
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more complicated than the one reflected by this given
model but the findings in this paper exhibit the different
possibilities and approaches of using mathematical
modeling and numerical simulations in order to achieve
new insights in more effective drug treatments.Appendix. Mathematical analysis
Lemma 1. The region UZ
n
T ; T);M ;M);
VÞ˛R5þ : T 
s
m
; T þ T) þM þM)  ðsþ lÞ
ε
;V 
hðsþ lÞ
cε
o
is positively invariant for the system (7).
This result is important from the physiological point
of view due to the fact that it ensures our mathematical
model is biologically relevant. The positive invariance
guarantees none of the populations, within the model,
either goes below zero or growth without a limit. In
other words, it assures that all populations are nonneg-
ative and finite at every time t.
The virus free equilibrium of the system (7) is given
by ðT0;0;M0;0;0ÞZðs=m; 0; l=r; 0; 0Þ and it belongs al-
ways to U. This equilibrium represents the situation
without infection in the body.
The basic reproduction number is given by the
expression [23]:
R0Z
h
d
bT 0
c
It denotes the number of secondary cases produced
by an infected cell during its lifespan into a susceptible
healthy CD4 T-cells population. Infected cells produce h
d
virions during its lifespan. These virions infect hb
dc
T0 on
the whole healthy CD4 T-cells population. This
dimensionless parameter is a key concept in mathe-
matical epidemiology or immunology. In fact, it de-
termines whether the disease/virus dies out or persists.
When R0 > 1, the infection becomes chronic. In this
case, it can be shown that the model supports a single
“endemic” state.Proposition 1. If R0 > 1, there exists a unique
endemic equilibrium of the system (7).
Proposition 2. If R0 < 1, the virus free equilibrium of
the system (7) is globally asymptotically stable.
The proofs of the above propositions and rigorous
mathematical analysiswill be given in our future research.Conflicts of interest
All authors declare no conflicts of interest.
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